SCHEMBL6205474

SCHEMBL6205474

NNc1cncc2c1cnn2-c1cccc(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TP53 P04637 8/20 0.40
MAPT P10636 8/20 0.40
GRM1 Q13255 1/20 0.40
LMNA P02545 6/20 0.40
DAPK3 O43293 1/20 0.39
PIM1 P11309 1/20 0.39
DAPK1 P53355 1/20 0.39
PIM3 Q86V86 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
DAPK2 Q9UIK4 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6390136 0.83 ALDH1A1 (0.48) NPC1RAB9AKMT2ASMN1; SMN2TP53
SCHEMBL6276508 0.82 NPC1 (0.46) NPC1RAB9AATMPKMKMT2A
SCHEMBL6274665 0.79 CCR1 (0.36) NPC1RAB9APKMKMT2ASMN1; SMN2
SCHEMBL6253146 0.77 GSK3B (0.40) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL6278086 0.77 GSK3B (0.49) NPC1RAB9AKMT2ASMN1; SMN2TP53
SCHEMBL6277293 0.75 XDH (0.43) NPC1RAB9APKMSMN1; SMN2TP53
SCHEMBL6237291 0.70 CYP17A1 (0.46) NPC1RAB9ATP53MAPTLMNA
SCHEMBL6204905 0.70 MAPT (0.71) KMT2ATP53MAPTLMNAHPGD
SCHEMBL6278822 0.69 RXFP1 (0.45) NPC1RAB9AMAPT
SCHEMBL6237563 0.68 GSK3B (0.43) PIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551841-A1 PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS SmithKline Beecham Corporation (US) 2005-07-13 EP disclosed
WO-2004009602-A1 PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-01-29 WO disclosed